Tectal plate glioma

View Details
Status
Done
logo
Parent item

General

  • A rare subtype of brainstem gliomas
  • Frequently considered to be a benign subgroup of astrocytoma
  • 4 principal types of tumour arises here:
    • Astrocytomas
      • Pilocystic astrocytomas are the most common
    • Ependymomas
    • Oligodendrogliomas
    • Mixed gliomas (i.e., oligoastrocytomas)

Number

  • Paeds
    • Tectal gliomas make up less than 5 % of the brainstem tumors in children
  • Adults
    • Focal tectal tumors constitute 8 % of all brainstem gliomas
      • Which in turn comprise 1 % of all the brain tumors in adults
  • There is no difference in incidence of brain stem gliomas according to sex or gender.
  • Mean age at the time of diagnosis was 7.7 years (standard deviation, 5.2 years)

Classification

Fisher et al. Classfication

  • Pilocytic astrocytoma
  • Fibrillary astrocytoma for brainstem gliomas

Oka et al classification:

  • Based on the magnetic resonance (MR) appearance and correlated the findings with the neuroendoscopic, histopathological, and postoperative clinical findings.

Group 1

  • MRI
    • Bulbous tectal mass,
    • Isotense on T1-weighted images
    • Hypertense on T2-weighted images
    • Does not have gadolinium enhancement.
  • Neuroendoscopic findings
    • Ill-defined mass in the cerebral aqueduct.
  • Pathology
    • Gliosis
  • Outcome
    • Complete resolution of symptoms

Group 2

  • MRI
    • An exophytic growth of the tectal mass into the cerebral aqueduct, extending into the diencephalon and midbrain tegmentum.
  • Neuroendoscopic findings
    • A wide orifice of the aqueduct is seen, with the protrusion of a soft, ill-defined, translucent, elastic mass. The posterior commissure was found to be deviated upwards.
  • Pathology
    • Benign astrocytoma
  • Outcome
    • Complete resolution of the signs and symptoms postoperatively.

Group 3

  • MRI
    • Large masses
    • Mixed intensities on both T1- and T2
    • Enhancement following gadolinium administration.
    • Exophytic growth of the tumor into the cerebral aqueduct and third ventricle with oppression of the posterior diencephalon and midbrain tegmentum was identified.
  • Neuroendoscopic findings
    • A large, well-demarcated, hemorrhagic, globular tumor in the orifice of the aqueduct.
    • It protruded into the cerebral aqueduct to extend into the third ventricle.
    • Upward deviation of the stretched-out posterior commissure was noted.
  • Pathology
    • Anaplastic astrocytoma.
  • Outcome
    • Symptoms from the hydrocephalus were controlled, while those from the tumor persisted

Clinical presentation

  • Increased ICP
    • Papilledema
    • Headache
    • Nausea, and/or vomiting
  • Gait ataxia
  • Decline in school performance
  • Parinaud’s syndrome
  • Decreased vision
  • Hemiparesis
  • Diplopia
  • Urinary incontinence
  • Personality changes

Imaging

CT

  • To show HCP
    • Most predominant finding.
  • Tectal tumors are usually small, appear isodense
  • Show either limited or absent contrast enhancement
  • Most cases in the past which relied exclusively on CT scans were misdiagnosed as congenital late-onset aqueductal stenosis

MRI

  • Gold standard
  • Characteristic appearance of tumor on MRI.
  • Focal gliomas are well-circumscribed, isodense or hypotense on T1-weighted images
  • Diffuse tumors tend to be hyperdense on T2-weighted images
  • The radiological diagnosis of midbrain tumors is evident when they extend ventrally; however, for imaging pattern of ventrally exophytic tumors, it is difficult to distinguish from pineal tumors; it should therefore be included in the differential diagnosis

Diagnosis

  • A definitive diagnosis requires the collection of a tissue specimen for histopathologic analysis.
  • The diagnosis of benign tectal glioma is made based on the radiographic appearance and the indolent clinical course of the lesions
  • According to reports from Fisher et al. [12], not all low-grade tumors are alike, and it is often difficult to distinguish pilocystic astrocytomas (grade I) from nonpilocystic astrocytomas (grade I) even after the histopathology has been determined.
    • In such cases, the typical MRI pattern of non-enhancement on pilocystic tumors and enhancement of nonpilocystic tumors may be a means of distinguishing the two groups.
  • Furthermore, some benign tumors will increase in size making further interventions necessary.

Management

Initially

  • Control HCP with CSF diversion
    • Aim to minimizing the signs and symptoms of increased intracranial pressure
    • EVD

Conservative/palliative

  • Generally indolent, clinically stable nature of the tumors.
  • long-term monitoring with serial MRI imaging

Surgery

Aims

  • Reduction of surgical mass
  • To obtain a histopathological sample

Indication

  • Cases demonstrating radiological tumor growth
  • Cases demonstrating worsening symptoms due to tumour
  • When definitive diagnosis is imperative
  • Low grade lesion
    • Treat HCP and survaillence
    • ETV
    • Endoscopic aqeuductoplasty
  • High grade lesion
    • Surgical resection

Endoscopic third ventriculostomy (ETV)

  • Highly effective for the management of HCP in patients with tectal gliomas
    • 70 % success rate in the treatment of aqueductal stenosis following the procedure
  • Gold standard for tx HCP secondary to tectal gliomas
    • A low morbidity and mortality,
    • Lower chance of re-obstruction compared to the shunting
  • Disadvantages
    • Acute hydrocephalus secondary to re-obstruction
      • Long-term follow-up involving periodic imaging, along with patient education addressing to prevent this
    • Possible basilar artery damage
    • Lack of longitudinal studies to determine the effectiveness

Endoscopic aqueductoplasty

  • Involves
    • Expansion of the CSF channel between the third and fourth ventricles.
    • Allows for biopsy collection.
  • Disadvantages
    • Potential for iatrogenic tectal injury

Surgical resection

  • Traditional approach to the management of tumors
  • Not recommended for the management of tectal gliomas due to the indolent, nondestructive nature of the tumors.
  • Indicated only if the tumor demonstrates
    • Growth in size or
    • A malignant, secondary, or vascular lesion is suspected.
  • Approaches
    • Supracerebellar–infratentorial midline approach
    • Suboccipital craniotomy
  • TPG may be difficult to remove due to the large volume and often inaccessible location
  • Complications
    • Postoperative Parinaud’s syndrome
    • Impaired eye movements
    • Auditory hallucinations
    • Bilateral optic nerve atrophy
    • Left hemianopsia (occipital lobe retraction)
    • Death after being in a vegetative state

Radiotherapy

  • To target a precise focal section with minimal damage to the surrounding structures.
  • External radiotherapy has been found to be relatively successful with no side effects
  • Focal radiotherapy was shown to provide good control of the tumor in rare, locally aggressive cases
  • In adults, focal radiotherapy, along with peritoneal shunting, is associated with increased rates of long-term survival
  • Cases treated with stereotactic radiosurgery have been reported to be effective; however, there was a reported extreme risk associated with a small increase in the dose
  • The use of gamma knife in focal tectal tumors is still under investigation

Chemotherapy

  • Along with radiotherapy may be attempted in cases where the complete removal of the infiltrating tumors is not possible.
  • Chemotherapy protocol(s), however, must be reserved for patients demonstrating clinical deterioration

Prognosis

  • Poor prognostic indicator
    • Fewer than 6 months of symptoms before diagnosis;
    • The presence of an abducens nerve palsy at time of presentation,
    • Engulfment of the basilar artery,
    • Pontine location.

Differential diagnosis

  • Aqueductal stenosis
    • No mass lesion
    • A focal stenosis or web may be visible
  • With larger lesions, where the mass is not definitely arising from the tectal plate then the differential is essentially that of a pineal region mass and therefore includes:
    • Pineal parenchymal tumours and germ cell tumours
    • Pineal cyst
    • Meningioma
    • Cerebral metastasis
    • Cavernous malformation
  • In patients with NF1 a hamartoma should also be considered. They tend to have some T1 hyperintensity 4

Reference